Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 NR4A2 ZNF724 ADNP2 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF510 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 LHX6 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

8.39e-1114128526GO:0000981
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 NR4A2 ZNF724 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF510 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 LHX6 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

1.72e-1014598526GO:0000977
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 NR4A2 ZNF724 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

2.13e-1012448524GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 NR4A2 ZNF724 ZNF816 ZNF521 NR4A3 ZBTB41 ZNF860 SNAI1 NR4A1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

3.29e-1012718524GO:0000987
GeneOntologyMolecularFunctionnuclear glucocorticoid receptor binding

NR4A2 NR4A3 NR4A1

8.05e-0520853GO:0035259
GeneOntologyMolecularFunctionglial cell-derived neurotrophic factor receptor activity

GFRA1 GFRA2

1.78e-045852GO:0016167
GeneOntologyMolecularFunctionthioredoxin-disulfide reductase (NADPH) activity

TXNRD1 TXNRD3

3.71e-047852GO:0004791
GeneOntologyMolecularFunctionzinc ion binding

TCEA1 TCEA2 TCEA3 ZNF117 ADAMTS2 NR4A2 KMT2A NR4A3 NR4A1 PHF8 ZMYM4 NUP153

3.79e-048918512GO:0008270
GeneOntologyMolecularFunctiontransition metal ion binding

TXNRD1 TCEA1 TCEA2 TCEA3 ZNF117 ADAMTS2 NR4A2 KMT2A CYP4F22 NR4A3 NR4A1 PHF8 ZMYM4 NUP153

4.67e-0411898514GO:0046914
GeneOntologyMolecularFunctionprotein-disulfide reductase (NAD(P)H) activity

TXNRD1 TXNRD3

6.32e-049852GO:0047134
GeneOntologyMolecularFunctionglycosaminoglycan binding

LAYN LIPG FGF7 APOH F11 GFRA2

9.97e-04268856GO:0005539
GeneOntologyMolecularFunctionserine-type exopeptidase activity

CTSA F11

1.15e-0312852GO:0070008
GeneOntologyMolecularFunctionoxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor

TXNRD1 TXNRD3

1.15e-0312852GO:0016668
GeneOntologyMolecularFunctionnuclear receptor activity

NR4A2 NR4A3 NR4A1

2.14e-0360853GO:0004879
GeneOntologyMolecularFunctionligand-activated transcription factor activity

NR4A2 NR4A3 NR4A1

2.24e-0361853GO:0098531
GeneOntologyMolecularFunctionsulfur compound binding

LIPG LRP1 FGF7 APOH F11 GFRA2

2.56e-03323856GO:1901681
GeneOntologyMolecularFunctionhistone methyltransferase binding

ZNF335 PRDM1

2.62e-0318852GO:1990226
GeneOntologyBiologicalProcesscellular response to corticotropin-releasing hormone stimulus

NR4A2 NR4A3 NR4A1

1.20e-066823GO:0071376
GeneOntologyBiologicalProcessresponse to corticotropin-releasing hormone

NR4A2 NR4A3 NR4A1

1.20e-066823GO:0043435
DomainZnf_C2H2

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 TAX1BP1 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1

1.28e-148058625IPR007087
DomainZnF_C2H2

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 TAX1BP1 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1

1.39e-148088625SM00355
DomainZINC_FINGER_C2H2_2

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1

5.19e-147758624PS50157
DomainZINC_FINGER_C2H2_1

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1

5.49e-147778624PS00028
Domainzf-C2H2_6

ZNF492 ZNF600 ZNF117 ZNF852 ZNF43 ZNF549 ZNF816 ZNF521 ZBTB41 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF879 PRDM1

6.21e-143148617PF13912
DomainZnf_C2H2-like

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 TAX1BP1 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

9.28e-147968624IPR015880
Domain-

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

2.93e-1367986223.30.160.60
Domainzf-C2H2

ZNF492 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 ZNF702P PRDM1

4.41e-136938622PF00096
DomainZnf_C2H2/integrase_DNA-bd

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

4.54e-136948622IPR013087
DomainKRAB

ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879

8.76e-083588612PS50805
DomainKRAB

ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879

8.76e-083588612PF01352
DomainTFSII

TCEA1 TCEA2 TCEA3

9.43e-083863IPR006289
DomainNuc_orph_rcpt

NR4A2 NR4A3 NR4A1

9.43e-083863IPR003070
DomainKRAB

ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879

1.22e-073698612SM00349
DomainKRAB

ZNF492 ZNF852 ZNF43 ZNF549 ZNF816 ZNF510 ZNF860 ZNF468 ZNF98 ZIM3 ZNF583 ZNF879

1.25e-073708612IPR001909
DomainTF_IIS-rel

TCEA1 TCEA2 TCEA3

3.76e-074863IPR016492
DomainZnf_TFIIS

TCEA1 TCEA2 TCEA3

1.87e-066863IPR001222
DomainZnF_C2C2

TCEA1 TCEA2 TCEA3

1.87e-066863SM00440
DomainZF_TFIIS_1

TCEA1 TCEA2 TCEA3

1.87e-066863PS00466
DomainZF_TFIIS_2

TCEA1 TCEA2 TCEA3

1.87e-066863PS51133
DomainTFIIS_C

TCEA1 TCEA2 TCEA3

1.87e-066863PF01096
DomainTFS2M

TCEA1 TCEA2 TCEA3

3.26e-067863SM00510
DomainTFIIS_M

TCEA1 TCEA2 TCEA3

3.26e-067863PF07500
DomainTFIIS_cen_dom

TCEA1 TCEA2 TCEA3

5.19e-068863IPR003618
Domain-

TCEA1 TCEA2 TCEA3

5.19e-0688631.10.472.30
DomainTFIIS_CENTRAL

TCEA1 TCEA2 TCEA3

5.19e-068863PS51321
DomainTFIIS/CRSP70_N_sub

TCEA1 TCEA2 TCEA3

1.11e-0510863IPR003617
DomainTFS2N

TCEA1 TCEA2 TCEA3

1.11e-0510863SM00509
DomainGlial_neurotroph_fac_rcpt_a1/2

GFRA1 GFRA2

2.10e-052862IPR017372
Domain-

TCEA1 TCEA2 TCEA3

2.61e-05138631.20.930.10
DomainTFIIS_N

TCEA1 TCEA2 TCEA3

2.61e-0513863PS51319
DomainMed26

TCEA1 TCEA2 TCEA3

2.61e-0513863PF08711
DomainTFIIS_N

TCEA1 TCEA2 TCEA3

3.31e-0514863IPR017923
DomainThioredoxin/glutathione_Rdtase

TXNRD1 TXNRD3

6.27e-053862IPR006338
DomainPyr_OxRdtase_I_AS

TXNRD1 TXNRD3

2.08e-045862IPR012999
DomainPyr_redox_dim

TXNRD1 TXNRD3

2.08e-045862PF02852
DomainGDNF_rcpt

GFRA1 GFRA2

2.08e-045862IPR003438
DomainPYRIDINE_REDOX_1

TXNRD1 TXNRD3

2.08e-045862PS00076
DomainGDNF

GFRA1 GFRA2

3.11e-046862SM00907
DomainGDNF

GFRA1 GFRA2

3.11e-046862PF02351
DomainGDNF/GAS1

GFRA1 GFRA2

3.11e-046862IPR016017
DomainGLUTAREDOXIN_1

TXNRD1 TXNRD3

3.11e-046862PS00195
Domain-

TXNRD1 TXNRD3

4.34e-0478623.30.390.30
DomainPyr_nucl-diS_OxRdtase_dimer

TXNRD1 TXNRD3

5.76e-048862IPR004099
DomainFAD/NAD-linked_Rdtase_dimer

TXNRD1 TXNRD3

5.76e-048862IPR016156
DomainGlutaredoxin

TXNRD1 TXNRD3

7.39e-049862PF00462
DomainGLUTAREDOXIN_2

TXNRD1 TXNRD3

7.39e-049862PS51354
DomainSET

KMT2A KMT2E PRDM1

8.85e-0441863PF00856
DomainGlutaredoxin

TXNRD1 TXNRD3

9.21e-0410862IPR002109
DomainSET

KMT2A KMT2E PRDM1

1.24e-0346863SM00317
Domainzf-C4

NR4A2 NR4A3 NR4A1

1.24e-0346863PF00105
DomainZnf_hrmn_rcpt

NR4A2 NR4A3 NR4A1

1.24e-0346863IPR001628
DomainNuclear_hrmn_rcpt

NR4A2 NR4A3 NR4A1

1.24e-0346863IPR001723
DomainNUCLEAR_REC_DBD_2

NR4A2 NR4A3 NR4A1

1.24e-0346863PS51030
DomainNUCLEAR_REC_DBD_1

NR4A2 NR4A3 NR4A1

1.24e-0346863PS00031
DomainZnF_C4

NR4A2 NR4A3 NR4A1

1.24e-0346863SM00399
Domain-

NR4A2 NR4A3 NR4A1

1.32e-03478631.10.565.10
DomainHOLI

NR4A2 NR4A3 NR4A1

1.40e-0348863SM00430
DomainNucl_hrmn_rcpt_lig-bd

NR4A2 NR4A3 NR4A1

1.40e-0348863IPR000536
DomainHormone_recep

NR4A2 NR4A3 NR4A1

1.40e-0348863PF00104
DomainSET_dom

KMT2A KMT2E PRDM1

1.58e-0350863IPR001214
DomainSET

KMT2A KMT2E PRDM1

1.58e-0350863PS50280
DomainAnticodon-bd

BRIX1 EIF2AK4

1.84e-0314862IPR004154
Domain-

NR4A2 NR4A3 NR4A1

2.31e-03578633.30.50.10
DomainZnf_NHR/GATA

NR4A2 NR4A3 NR4A1

2.42e-0358863IPR013088
DomainEGF

LRP1 SCUBE3 AREG TMEFF2

2.74e-03126864PF00008
DomainPrtase_inh_Kunz-CS

SPINT2 EPPIN

3.06e-0318862IPR020901
DomainKU

SPINT2 EPPIN

3.06e-0318862SM00131
DomainPLAC

ADAMTSL1 ADAMTS2

3.41e-0319862PS50900
DomainBPTI_KUNITZ_2

SPINT2 EPPIN

3.41e-0319862PS50279
DomainPLAC

ADAMTSL1 ADAMTS2

3.41e-0319862IPR010909
DomainKunitz_BPTI

SPINT2 EPPIN

3.41e-0319862PF00014
DomainPyr_redox_2

TXNRD1 TXNRD3

3.41e-0319862PF07992
DomainBPTI_KUNITZ_1

SPINT2 EPPIN

3.41e-0319862PS00280
PathwayREACTOME_RNA_POLYMERASE_II_TRANSCRIPTION

TXNRD1 TCEA1 ZNF492 ZNF600 ZNF43 USP9X ZNF549 ICE2 NR4A2 ZNF724 ZNF521 KMT2A NR4A3 RFFL ZNF510 ZNF860 NR4A1 ZNF468 ZIM3 ZNF583 PRDM1

5.31e-0713876521M734
Pubmed

Nuclear receptors of the NR4a family are not required for the development and function of follicular T helper cells.

NR4A2 NR4A3 NR4A1

1.51e-08387325899083
Pubmed

NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors.

NR4A2 NR4A3 NR4A1

1.51e-08387322996661
Pubmed

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

NR4A2 NR4A3 NR4A1

1.51e-08387327159982
Pubmed

Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.

NR4A2 NR4A3 NR4A1

1.51e-08387318945812
Pubmed

The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.

NR4A2 NR4A3 NR4A1

1.51e-08387322143616
Pubmed

Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses.

NR4A2 NR4A3 NR4A1

1.51e-08387316873729
Pubmed

The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice.

NR4A2 NR4A3 NR4A1

1.51e-08387325605333
Pubmed

Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli.

NR4A2 NR4A3 NR4A1

1.51e-08387315964844
Pubmed

Relevance of the NR4A sub-family of nuclear orphan receptors in trophoblastic BeWo cell differentiation.

NR4A2 NR4A3 NR4A1

1.51e-08387328808448
Pubmed

The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetes.

NR4A2 NR4A3 NR4A1

1.51e-08387325199433
Pubmed

NR4A nuclear receptors in immunity and atherosclerosis.

NR4A2 NR4A3 NR4A1

1.51e-08387324005216
Pubmed

Minireview: What is Known about SUMOylation Among NR4A Family Members?

NR4A2 NR4A3 NR4A1

1.51e-08387334437889
Pubmed

Stress and glucocorticoid regulation of NR4A genes in mice.

NR4A2 NR4A3 NR4A1

1.51e-08387324753204
Pubmed

Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation.

NR4A2 NR4A3 NR4A1

1.51e-08387321621845
Pubmed

Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

NR4A2 NR4A3 NR4A1

1.51e-08387310523643
Pubmed

Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder.

NR4A2 NR4A3 NR4A1

1.51e-08387320659174
Pubmed

Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.

NR4A2 NR4A3 NR4A1

1.51e-08387336482877
Pubmed

Nuclear receptor 4A (NR4A) family - orphans no more.

NR4A2 NR4A3 NR4A1

1.51e-08387325917081
Pubmed

FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts.

NR4A2 NR4A3 NR4A1

1.51e-08387318809462
Pubmed

NR4A transcription factors limit CAR T cell function in solid tumours.

NR4A2 NR4A3 NR4A1

1.51e-08387330814732
Pubmed

The NR4A orphan nuclear receptors: mediators in metabolism and diseases.

NR4A2 NR4A3 NR4A1

1.51e-08387325089663
Pubmed

Beta-adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues.

NR4A2 NR4A3 NR4A1

1.51e-08387319465082
Pubmed

MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling.

NR4A2 NR4A3 NR4A1

1.51e-08387315910281
Pubmed

TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.

NR4A2 NR4A3 NR4A1

6.04e-08487331152140
Pubmed

Trained immunity induced by high-salt diet impedes stroke recovery.

NR4A2 NR4A3 NR4A1

6.04e-08487337965920
Pubmed

Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis.

NR4A2 NR4A3 NR4A1

6.04e-08487323334790
Pubmed

Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.

NR4A2 NR4A3 NR4A1

6.04e-08487337961948
Pubmed

Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability.

NR4A2 NR4A3 NR4A1

6.04e-08487322789442
Pubmed

Nr4a Receptors Regulate Development and Death of Labile Treg Precursors to Prevent Generation of Pathogenic Self-Reactive Cells.

NR4A2 NR4A3 NR4A1

6.04e-08487330089271
Pubmed

Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo.

NR4A2 NR4A3 NR4A1

6.04e-08487315910753
Pubmed

Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.

NR4A2 NR4A3 NR4A1

6.04e-08487314525795
Pubmed

Regulation of peripheral Th/Treg differentiation and suppression of airway inflammation by Nr4a transcription factors.

NR4A2 NR4A3 NR4A1

6.04e-08487333665581
Pubmed

Heterogeneity and tissue-specific expression of eukaryotic transcription factor S-II-related protein mRNA.

TCEA1 TCEA2 TCEA3

1.51e-0758731917889
Pubmed

The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.

NR4A2 NR4A3 NR4A1

1.51e-07587315155786
Pubmed

Transcription elongation factor Tcea3 regulates the pluripotent differentiation potential of mouse embryonic stem cells via the Lefty1-Nodal-Smad2 pathway.

TCEA1 TCEA2 TCEA3

1.51e-07587323169579
Pubmed

Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells.

NR4A2 NR4A3 NR4A1

1.51e-07587326304965
Pubmed

Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1.

NR4A2 NR4A3 NR4A1

1.51e-0758738961274
Pubmed

NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells.

NR4A2 NR4A3 NR4A1

3.01e-07687325809189
Pubmed

Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation.

NR4A2 NR4A3 NR4A1

8.39e-07887316223362
Pubmed

GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons.

LHX6 GFRA1 GFRA2

1.79e-061087315748846
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

MORF4L2 USP9X SYNE1 SMC1A NR4A2 ADNP2 LRP1 ZNF521 RAB11FIP4 CTNND2 ZBTB11 ZNF583 ZMYM4 ZNF879

3.59e-061285871435914814
Pubmed

Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors NR4A2 and NR4A3 Reveals Distinct Signalling Roles Related to Antigen Presentation and Viral Response.

NR4A2 NR4A3

6.19e-06287234248958
Pubmed

Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins.

GFRA1 GFRA2

6.19e-0628729177201
Pubmed

Compensatory Expression of Nur77 and Nurr1 Regulates NF-κB-Dependent Inflammatory Signaling in Astrocytes.

NR4A2 NR4A1

6.19e-06287230111648
Pubmed

Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory.

NR4A2 NR4A1

6.19e-06287223161447
Pubmed

The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass.

NR4A3 NR4A1

6.19e-06287230696767
Pubmed

Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis.

NR4A3 NR4A1

6.19e-06287220411565
Pubmed

Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.

NR4A2 NR4A1

6.19e-06287221480782
Pubmed

NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.

NR4A3 NR4A1

6.19e-06287228249906
Pubmed

Molecular signatures of thyroid follicular neoplasia.

NR4A3 NR4A1

6.19e-06287220668010
Pubmed

ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.

ZNF521 KMT2A

6.19e-06287228412727
Pubmed

The orphan nuclear receptors NURR1 and NGFI-B modulate aromatase gene expression in ovarian granulosa cells: a possible mechanism for repression of aromatase expression upon luteinizing hormone surge.

NR4A2 NR4A1

6.19e-06287215486232
Pubmed

A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.

NR4A2 NR4A3

6.19e-06287236469101
Pubmed

The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.

NR4A3 NR4A1

6.19e-06287225410408
Pubmed

Molecular cloning of cDNA and tissue-specific expression of the gene for SII-K1, a novel transcription elongation factor SII.

TCEA1 TCEA3

6.19e-0628729685180
Pubmed

Deficiency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury.

NR4A3 NR4A1

6.19e-06287219153266
Pubmed

Orphan Nuclear Receptor Family 4A (NR4A) Members NR4A2 and NR4A3 Selectively Modulate Elements of the Monocyte Response to Buffered Hypercapnia.

NR4A2 NR4A3

6.19e-06287238474099
Pubmed

HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML.

NR4A3 NR4A1

6.19e-06287223247046
Pubmed

Transcription factor genes and the developing eye: a genetic perspective.

TCEA2 TCEA3

6.19e-0628728875254
Pubmed

Nur-related factor 1 and nerve growth factor-induced clone B in human adrenal cortex and its disorders.

NR4A2 NR4A1

6.19e-06287215292355
Pubmed

Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.

NR4A3 NR4A1

6.19e-06287217515897
Pubmed

Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.

NR4A3 NR4A1

6.19e-06287221205929
Pubmed

CUG start codon generates thioredoxin/glutathione reductase isoforms in mouse testes.

TXNRD1 TXNRD3

6.19e-06287220018845
Pubmed

Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.

NR4A2 NR4A3

6.19e-06287232341238
Pubmed

Cloning, mRNA distribution and chromosomal localisation of the gene for glial cell line-derived neurotrophic factor receptor beta, a homologue to GDNFR-alpha.

GFRA1 GFRA2

6.19e-0628729259272
Pubmed

Identification of a new brain-specific transcription factor, NURR1.

NR4A2 NR4A1

6.19e-0628721491694
Pubmed

NR4A orphan nuclear receptor family members, NR4A2 and NR4A3, regulate neutrophil number and survival.

NR4A2 NR4A3

6.19e-06287228637666
Pubmed

BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.

NR4A3 PRDM1

6.19e-06287236350986
Pubmed

TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.

NR4A2 NR4A3 NR4A1

6.73e-061587319321449
Pubmed

Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice.

NR4A2 NR4A3 NR4A1

8.27e-061687328170423
Pubmed

HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.

TCEA1 TCEA2 TCEA3

1.00e-05178731559613
Pubmed

Identification of a Pax6-dependent epidermal growth factor family signaling source at the lateral edge of the embryonic cerebral cortex.

FGF7 AREG TMEFF2

1.42e-051987312878679
Pubmed

GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival.

GFRA1 GFRA2

1.85e-05387210774729
Pubmed

Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia.

NR4A3 NR4A1

1.85e-05387223552735
Pubmed

Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair.

NR4A2 NR4A1

1.85e-05387221979916
Pubmed

Angiotensin II triggers expression of the adrenal gland zona glomerulosa-specific 3β-hydroxysteroid dehydrogenase isoenzyme through de novo protein synthesis of the orphan nuclear receptors NGFIB and NURR1.

NR4A2 NR4A1

1.85e-05387225092869
Pubmed

Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.

GFRA1 GFRA2

1.85e-05387212490080
Pubmed

Neurotrophin and GDNF family ligands promote survival and alter excitotoxic vulnerability of neurons derived from murine embryonic stem cells.

GFRA1 GFRA2

1.85e-05387215589513
Pubmed

NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3.

NR4A2 NR4A1

1.85e-0538727877627
Pubmed

Microbiota-derived short chain fatty acid promotion of Amphiregulin expression by dendritic cells is regulated by GPR43 and Blimp-1.

AREG PRDM1

1.85e-05387232958255
Pubmed

NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling.

NR4A3 NR4A1

1.85e-05387229343483
Pubmed

Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.

NR4A2 NR4A1

1.85e-05387215591535
Pubmed

Deficiency of the NR4A orphan nuclear receptor NOR1 decreases monocyte adhesion and atherosclerosis.

NR4A3 NR4A1

1.85e-05387220558821
Pubmed

Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases.

TXNRD1 TXNRD3

1.85e-05387210455115
Pubmed

Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems.

TXNRD1 TXNRD3

1.85e-05387211259642
Pubmed

Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.

NR4A3 NR4A1

1.85e-0538729155013
Pubmed

Isolation and characterization of a cDNA encoding a new type of human transcription elongation factor S-II.

TCEA1 TCEA2

1.85e-0538728566795
Pubmed

Antithrombotic Effects of Nur77 and Nor1 Are Mediated Through Upregulating Thrombomodulin Expression in Endothelial Cells.

NR4A3 NR4A1

1.85e-05387226634653
Pubmed

Orphan nuclear receptors in T lymphocyte development.

NR4A3 NR4A1

1.85e-05387212223510
Pubmed

Tissue distribution of Ret, GFRalpha-1, GFRalpha-2 and GFRalpha-3 receptors in the human brainstem at fetal, neonatal and adult age.

GFRA1 GFRA2

1.85e-05387217825269
Pubmed

Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.

NR4A2 NR4A1

1.85e-05387230106181
Pubmed

B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.

NR4A3 NR4A1

1.85e-05387229414782
Pubmed

Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.

NR4A2 NR4A1

1.85e-05387226148973
Pubmed

Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor.

GFRA1 GFRA2

1.85e-05387210069331
Pubmed

Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.

GFRA1 GFRA2

1.85e-05387220116071
Pubmed

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'.

LRP1 APOH

1.85e-05387212807892
Pubmed

Site-specific gene expression and localization of growth factor ligand receptors RET, GFRα1 and GFRα2 in human adult colon.

GFRA1 GFRA2

1.85e-05387223881409
Pubmed

Genome-scale study of transcription factor expression in the branching mouse lung.

TCEA1 TCEA2 SNAI1 LHX6

2.48e-056787422711520
Pubmed

Molecular cloning and characterization of cDNA for eukaryotic transcription factor S-II.

TCEA1 TCEA3

3.70e-0548723346229
Pubmed

GFRalpha-3, a protein related to GFRalpha-1, is expressed in developing peripheral neurons and ensheathing cells.

GFRA1 GFRA2

3.70e-0548729749804
Cytoband19q13.41

ZNF600 ZNF816 ZNF468 ZNF702P

1.61e-057888419q13.41
Cytoband12q23-q24.1

TXNRD1 PLA2G1B

5.42e-05688212q23-q24.1
CytobandEnsembl 112 genes in cytogenetic band chr19p12

ZNF492 ZNF43 ZNF724 ZNF98

9.31e-05122884chr19p12
Cytoband19p12

ZNF492 ZNF724 ZNF98

7.09e-049088319p12
CytobandXq22

MORF4L2 FRMPD3

8.18e-0422882Xq22
CytobandEnsembl 112 genes in cytogenetic band chr20q13

TCEA2 EPPIN ZNF335 SNAI1 CTSA

1.34e-03422885chr20q13
CytobandEnsembl 112 genes in cytogenetic band chr19q13

ZNF600 SPINT2 ZNF549 ZNF816 ZNF468 ZIM3 ZNF583 ZNF702P

2.08e-031192888chr19q13
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF492 ZNF800 ZNF600 ZNF117 ZNF852 ZNF341 ZNF43 ZNF549 ZNF335 ADNP2 ZNF816 ZNF521 ZBTB41 ZNF510 ZNF860 SNAI1 ZNF468 ZBTB11 ZNF98 ZIM3 ZNF583 ZNF879 PRDM1

8.85e-17718632328
GeneFamilyNuclear hormone receptors

NR4A2 NR4A3 NR4A1

6.63e-044963371
GeneFamilySelenoproteins

TXNRD1 TXNRD3

3.40e-0325632890
GeneFamilyPHD finger proteins

KMT2A PHF8 KMT2E

3.82e-039063388
CoexpressionGSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN

TXNRD1 NR4A2 NR4A3 NR4A1 DCTN4 TASL AREG

3.61e-06192877M4154
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPINT2 LAYN NR4A2 NR4A3 EIF2AK4 SNAI1 AREG

1.06e-071918876cda82a994f4b205cf54590c979d7c9f3be2b4c8
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPINT2 LAYN NR4A2 NR4A3 EIF2AK4 SNAI1 AREG

1.06e-071918874257f02856f3510981e9f84d465d91448d6126e2
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPINT2 LAYN NR4A2 NR4A3 EIF2AK4 SNAI1 AREG

1.06e-071918872699e9bb872f2b561bb976dfdc2746e359bc9daf
ToppCell(3)_MNP-(3)_DC_2|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

SPINT2 NR4A2 NR4A3 NR4A1 TASL AREG PRDM1

1.06e-071918873ff163484af8c12ef4eef87246cf044257fd2547
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPINT2 LAYN NR4A2 NR4A3 EIF2AK4 SNAI1 AREG

1.06e-071918874b94c8b0183ae07d173646b7e7e1d9db04ec9637
ToppCellControl-cDC-|Control / Disease condition and Cell class

TCEA3 SPINT2 LAYN NR4A2 NR4A3 EIF2AK4 AREG

1.22e-07195887a2b4d9473eff73f088b247ce43e66f013622471e
ToppCellControl-cDC|Control / Disease condition and Cell class

TCEA3 SPINT2 LAYN NR4A2 NR4A3 EIF2AK4 AREG

1.22e-07195887b96acdd22dd3885af69328f170ea871a0d570034
ToppCellCOVID-19_Severe-cDC|COVID-19_Severe / disease group, cell group and cell class

LAYN NR4A2 EMILIN2 NR4A3 SNAI1 NR4A1 AREG

1.22e-071958876419090b19de7b5d5140eaecf231860273da2c0d
ToppCellmild_COVID-19-cDC|World / disease group, cell group and cell class (v2)

SPINT2 LAYN NR4A3 EIF2AK4 SNAI1 NR4A1 AREG

1.30e-0719788763e7b040c64f1e28b8db79980c7b580caa7d1b95
ToppCellBAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters

NR4A2 EMILIN2 NR4A3 SNAI1 NR4A1 AREG PRDM1

1.30e-071978878a3fe59be3ed1f0254cc8c60b99c840193370efb
ToppCellEntopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

NR4A2 NR4A3 SNAI1 NR4A1 AREG PRDM1

6.76e-07156886029ba0832ee9c4a2c85620e4df2260e02d86b45c
ToppCellEntopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

NR4A2 NR4A3 SNAI1 NR4A1 AREG PRDM1

6.76e-071568865df19a235843829f5a1a90ca21b0964ef8b4e115
ToppCellmetastatic_Lymph_Node-Myeloid_cells-CD1c+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass

ZNF521 NR4A3 SNAI1 NR4A1 TASL GFRA2

1.66e-06182886551d301adfb4d5046c5f60f6996450621b04e9b2
ToppCellPBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters

NR4A2 NR4A3 SNAI1 NR4A1 AREG PRDM1

1.94e-061878860afef5baf3752314dbfb024790347d5e51f9b84b
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPINT2 LAYN NR4A2 NR4A3 SNAI1 NR4A1

2.00e-061888868431991e68b8e9c5eb72212460f6da679ea3b85a
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_8|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPINT2 LAYN NR4A2 NR4A3 SNAI1 NR4A1

2.00e-06188886d8f10b3ad11bc99a63f44560e39791085256e5c8
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPINT2 LAYN NR4A3 SNAI1 NR4A1 AREG

2.07e-06189886c81b38cda4525254fe4fa137a4c9bc9abe0363bb
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPINT2 LAYN NR4A3 SNAI1 NR4A1 AREG

2.07e-06189886807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPINT2 NR4A2 NR4A3 NR4A1 GFRA2 AREG

2.20e-0619188692c5a26b90a55831039220341d863cf2940f3c9b
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPINT2 NR4A2 NR4A3 NR4A1 GFRA2 AREG

2.26e-061928866184163dbfca882824cb266bb9030d9f79e3acb0
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SPINT2 NR4A2 NR4A3 SNAI1 NR4A1 AREG

2.26e-06192886dfb9101622f7d2f2c392e850cff07becfc8c655e
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPINT2 NR4A2 NR4A3 SNAI1 NR4A1 AREG

2.26e-06192886d39133cf1a20af6f2970188630fc3b27a4cfc9c5
ToppCell367C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SPINT2 NR4A2 NR4A3 NR4A1 TASL AREG

2.33e-06193886940e9a419d0de1f9e72b5cc9c86684057003be58
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NR4A2 NR4A3 SNAI1 NR4A1 AREG PRDM1

2.33e-06193886704378de39e1b6f108ab5b0ecbd594d414ec8ae4
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZNF600 SYNE1 SMC1A PLA2G1B CMC4 AREG

2.40e-061948866be74e4ba631b0c46cef2c580553f4c1ed29579e
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NR4A2 NR4A3 SNAI1 NR4A1 AREG PRDM1

2.40e-0619488636f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b
ToppCell343B-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SPINT2 NR4A2 NR4A3 NR4A1 TASL AREG

2.40e-06194886ccb04f0788c98e0f63f18b09484d75ac536412a1
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADAMTSL1 ADAMTS2 FGF7 NR4A3 NR4A1 GFRA1

2.48e-06195886ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCellmetastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass

SPINT2 NR4A2 NR4A3 NR4A1 AREG PRDM1

2.48e-061958867fb5c0911ff09580515d1a1827d7249d6242630c
ToppCellCOVID-19_Moderate-cDC|World / disease group, cell group and cell class

SPINT2 EMILIN2 NR4A3 EIF2AK4 SNAI1 NR4A1

2.55e-0619688692a236adf386f05d020b1954bbdc5bd32346cbf0
ToppCelltumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass

NR4A2 NR4A3 SNAI1 NR4A1 KMT2E PRDM1

2.55e-061968867aa6778b78a8549dd4d0a5278ef8017334b00c38
ToppCellCOVID-19_Mild-cDC|COVID-19_Mild / Disease condition and Cell class

TCEA3 SPINT2 LAYN NR4A2 NR4A3 AREG

2.63e-0619788609045845891de79164124afb6c632e2838906006
ToppCellnormal_Lymph_Node-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass

SPINT2 NR4A2 NR4A3 SNAI1 NR4A1 AREG

2.63e-061978862b3cd318c988364adcba4441444045914d58fe46
ToppCellCOVID-19_Mild-cDC-|COVID-19_Mild / Disease condition and Cell class

TCEA3 SPINT2 LAYN NR4A2 NR4A3 AREG

2.63e-0619788661d6dd023b2ba2bc76f17c06f7c30434ed865171
ToppCellmLN-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass

TCEA1 NR4A2 NR4A3 NR4A1 CTSA AREG

2.70e-06198886e2c63ca9f82f8524447e398b11a676b22d2f58ce
ToppCelltumor_Lung-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass

SPINT2 NR4A2 NR4A3 SNAI1 NR4A1 AREG

2.70e-06198886edd8ad006c4c7516491e52cc8adad20297837e5b
ToppCellCOVID-19_Severe-cDC|World / disease group, cell group and cell class

SPINT2 EMILIN2 NR4A3 SNAI1 NR4A1 AREG

2.70e-06198886c452334249f047265ae89dcabe7de446d968cae6
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LRP1 ZNF521 FGF7 NR4A1 ZNF98 GFRA1

2.78e-06199886abd6117f8a3d7e798d8471c16d97b34aaf50fc9c
ToppCellControl-Control-Myeloid-cDC|Control / Disease, condition lineage and cell class

SPINT2 LAYN NR4A2 EMILIN2 NR4A3 EIF2AK4

2.86e-062008861375d199320feb85ba06e74b10df6521e790addf
ToppCellCOVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class

SPINT2 LAYN NR4A3 EIF2AK4 NR4A1 AREG

2.86e-06200886e7b808d8ed65343a4345fafb03015fe4f7ce302f
ToppCellTracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTS2 SYNE1 LRP1 ZNF521 FGF7 GFRA1

2.86e-06200886b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCellBiopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type

SPINT2 NR4A2 NR4A3 EIF2AK4 TASL AREG

2.86e-062008868e455f685f0a9c63e83d6d339d7767f0e9841c6e
ToppCellParenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

NR4A2 EMILIN2 LRP1 NR4A3 NR4A1 AREG

2.86e-0620088609bac15df511687ff336c1e7a67d980c6c281f79
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTSL1 ADAMTS2 SYNE1 LRP1 FGF7 GFRA1

2.86e-062008860c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCellRA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

MFSD2A LAYN ZNF852 NR4A3 AREG

8.06e-061388855a713f24f633de463ef47ca37fbb2bb60c7fdb77
ToppCell343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

ADAMTS2 NR4A2 NR4A3 NR4A1 AREG

1.37e-05154885874b1220337276489a89fcc9a39bc81ba6b68baf
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

EMILIN2 CTNND2 LHX6 TMEFF2 PRDM1

1.42e-051558855c7b68b59244525e3714806c205a57a2daebf423
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NR4A2 NR4A3 NR4A1 TASL AREG

1.70e-051618857e0b8119cea208c0b4a0dffdf94ff6137d0b4c90
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NR4A2 NR4A3 NR4A1 TASL AREG

1.75e-051628852fd6e8f48b48d509a7533cec2f79089513c34a2f
ToppCellnormal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass

NR4A2 NR4A3 NR4A1 AREG PRDM1

1.80e-051638857d7f18e5c99be125e95bc180823430291b770d05
ToppCellnormal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass

NR4A2 NR4A3 NR4A1 AREG PRDM1

1.97e-0516688507b498eb341abec02a3ccaae320bdbb5cd6883c5
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class

MFSD2A NR4A2 NR4A3 NR4A1 AREG

2.09e-05168885ea465152ea31391b63c02425beafa9a4f51f6703
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 EMILIN2 LRP1 TMEFF2

2.15e-05169885bb43abad2c049b7f4d307737347290e01b3339a3
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 EMILIN2 LRP1 TMEFF2

2.15e-051698855f18e3f40a5b1b167903f37516ec8181e889c7c5
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 EMILIN2 LRP1 TMEFF2

2.15e-051698858bfa2d3bb541d02f55d7c95b8fd156c8403befca
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NR4A2 LRP1 NR4A3 NR4A1 GFRA2

2.27e-051718855e93c76ee60f9d0590ebb140812653a5e1369417
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTSL1 LRP1 FGF7 GFRA1 TMEFF2

2.34e-05172885e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class

MFSD2A NR4A2 NR4A3 NR4A1 AREG

2.40e-05173885502f888b7684ed39f5c577eedcacf673ae81d39e
ToppCellfacs-SCAT-Fat-24m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFSD2A SPINT2 NR4A3 F11 AREG

2.54e-05175885d82153bdb0c5cca96485d6b0579440f9c9e3abe2
ToppCelldroplet-Kidney-nan-21m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 PLA2G1B RAB11FIP4 AREG PRDM1

2.61e-05176885feafc757e7aa4f17128ff34886beb2fd3461c9ea
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LAYN NR4A2 NR4A3 NR4A1 AREG

2.68e-051778853a150dcaefa342d49968b42c7cdb1fbb633adcd0
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LAYN NR4A2 NR4A3 NR4A1 AREG

2.68e-05177885c9e5820ff0bc7ad1adcfb2651713fdfc58bced56
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9

ADAMTSL1 ADAMTS2 SYNE1 LRP1 FGF7

2.75e-05178885142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCellnormal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass

NR4A2 NR4A3 TASL AREG PRDM1

2.75e-05178885b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9
ToppCellCD8+_Memory_T_cell-FLU-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

TCEA3 SPINT2 LAYN ZC3HAV1L SNAI1

2.83e-051798857f18dffa85285599662edbcd3f32ab42672bffb8
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TXNRD1 EMILIN2 NR4A3 EIF2AK4 TMEM9B

2.98e-05181885c8286a7ac8e3cc5aa7e92b043a08435294ea686f
ToppCellmild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2)

SPAG1 ZNF600 NR4A2 NR4A3 AREG

3.14e-051838859a4899afac0f91203209392c5f67b3d0aa356b86
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 ADAMTS2 LRP1 FGF7 GFRA1

3.22e-05184885e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTS2 NR4A2 EMILIN2 NR4A3 SNAI1

3.22e-05184885d1ea2b60fb1ca1a0b809d131310c43903a9e84ce
ToppCellnormal-na-Myeloid-conventional_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

SPINT2 LAYN EMILIN2 EIF2AK4 AREG

3.31e-0518588567e881a89a491665b8c612fff084c202c0c79235
ToppCellSmart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SYNE1 NR4A2 NR4A1 AREG PRDM1

3.40e-05186885fc0b488c201a32d829047b58460297df2818b45d
ToppCellNS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ADAMTS2 EMILIN2 NR4A3 SNAI1 TASL

3.48e-05187885fcc32dbc9c5ae6176f154715a3e73aa32d78ad64
ToppCell3'_v3-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue

SPINT2 MUC19 NR4A3 EIF2AK4 AREG

3.48e-051878859f3db9f0e5de34aeabfe5984f675bc7a65435df7
ToppCellCOVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

ADAMTSL1 ADAMTS2 FGF7 NR4A3 GFRA1

3.48e-0518788576bfe8c42430a230a8bdf299575c444fb7780f24
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SPINT2 LAYN CTSA GFRA1 AREG

3.48e-05187885e5713a7bda53d1d5178ab4e0dbadc2292b6005bc
ToppCellSmart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SYNE1 NR4A2 NR4A1 AREG PRDM1

3.48e-051878856981b856187a2e689260ecb7d0a1193a374ee9b9
ToppCell3'_v3-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue

SPINT2 EMILIN2 NR4A3 EIF2AK4 AREG

3.57e-05188885411d4dd5c9dee7ebd8db352640cf009e7b033ba9
ToppCellControl-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations)

ADAMTSL1 LRP1 ZNF521 FGF7 GFRA1

3.57e-05188885706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCelldroplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 EMILIN2 LRP1 TMEFF2

3.57e-051888857191087d8754f5e8700e3d744cd920ee26db1e57
ToppCellmetastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass

NR4A2 NR4A3 SNAI1 NR4A1 PRDM1

3.57e-051888855d12afb483d028ca02b3b4215131f6128e8bcd48
ToppCelldroplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 LRP1 FGF7 TMEFF2

3.66e-05189885544d95df910f1b276995624509a7e41b219baca0
ToppCellLV-14._Fibroblast_III|World / Chamber and Cluster_Paper

NR4A2 ZNF521 FGF7 NR4A3 NR4A1

3.66e-051898853922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TXNRD1 SPINT2 NR4A2 NR4A3 NR4A1

3.76e-0519088592456f6f7eced6e4c4371f495254a65d061c8d0b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 ADAMTS2 SYNE1 FGF7 NUP153

3.76e-051908851121eb607a984c59fbffe7220837fc178745aa55
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor

ADAMTSL1 ZNF521 FGF7 FRMPD3 GFRA1

3.76e-051908857dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCellBAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPAG1 NR4A2 ZNF724 NR4A3 NR4A1

3.76e-05190885da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 ADAMTS2 SYNE1 FGF7 NUP153

3.76e-05190885048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellBAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPAG1 NR4A2 ZNF724 NR4A3 NR4A1

3.76e-0519088542312f7d79fe889397d32910b625793e2535cc26
ToppCellBAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SPAG1 NR4A2 ZNF724 NR4A3 NR4A1

3.76e-05190885682418a7a2096743112eae3790d40e7e600612c0
ToppCellILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NR4A2 NR4A3 NR4A1 AREG PRDM1

3.76e-051908854395dbd18c14d491f5066a2ddac438a16b1fd7c3
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 ADAMTS2 LRP1 FGF7 GFRA1

3.85e-05191885a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SPINT2 NR4A2 NR4A3 NR4A1 AREG

3.85e-051918857bad04f8afa949ea952c5c0d71eec43271ade680
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 ADAMTS2 LRP1 FGF7 GFRA1

3.85e-051918858f6d592edc32fdb901af30501d4360512334e8c2
ToppCelldroplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 LRP1 FGF7 TMEFF2

3.95e-0519288538d7a24ae205ef91ed2e0f402d8022f2a9cdb243
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 ADAMTS2 LRP1 FGF7 GFRA1

3.95e-05192885bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCellBronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

SPAG1 EPPIN TMEM232 SYNE1 CFAP70

3.95e-05192885be592e661367affced9ebe80849b466e6adb3a34
ToppCelldroplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 ADAMTS2 LRP1 FGF7 TMEFF2

3.95e-0519288504d155897ed075c359933080e36a4ab2150b6e9f
ToppCellILEUM-non-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TCEA1 NR4A2 NR4A3 NR4A1 CTSA

3.95e-0519288537d0d0fdd6bc3114d546020b472b6df9392392f4
ToppCell356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

SPINT2 NR4A2 NR4A3 NR4A1 TASL

3.95e-05192885a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890
ToppCell367C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NR4A2 NR4A3 SNAI1 NR4A1 AREG

3.95e-0519288526326d7c3d907d754e85e128b7d8a52e90863f3f
DiseaseGrowth Deficiency and Mental Retardation with Facial Dysmorphism

SMC1A KMT2A

7.26e-062802C1854630
DiseaseMyeloid Leukemia

SMC1A KMT2A KMT2E

1.52e-0518803C0023470
DiseaseLeukemia, Monocytic, Chronic

SMC1A KMT2A KMT2E

1.52e-0518803C0023466
Diseaseprostate cancer (is_marker_for)

KMT2A FGF7 PHF8 KMT2E TMEFF2

6.76e-05156805DOID:10283 (is_marker_for)
DiseaseParkinsonism (biomarker_via_orthology)

NR4A2 GFRA1 GFRA2

1.08e-0434803DOID:0080855 (biomarker_via_orthology)
DiseaseCornelia De Lange Syndrome

SMC1A KMT2A

2.01e-048802C0270972
DiseaseSchizophrenia

NR4A2 ADNP2 LRP1 PLA2G1B KMT2A CTNND2 APOH LHX6 GFRA1

6.41e-04883809C0036341
DiseaseAutosomal recessive primary microcephaly

MFSD2A ZNF335

7.45e-0415802cv:C3711387
Diseasemigraine without aura, susceptibility to, 4

LRP1 GFRA1

8.50e-0416802MONDO_0011847
DiseaseIntellectual Disability

MFSD2A SYNE1 ZNF335 NR4A2 KMT2E ZBTB11

1.37e-03447806C3714756
Diseasephysical activity

ADAMTSL1 LIPG ZNF521

1.78e-0388803EFO_0003940
Diseasepartial thromboplastin time

APOH F11

1.93e-0324802EFO_0004310
DiseaseNeurodevelopmental Disorders

SMC1A KMT2A KMT2E

2.09e-0393803C1535926
Diseasemyocardial infarction (is_implicated_in)

LIPG LRP1 APOH

2.50e-0399803DOID:5844 (is_implicated_in)
Diseasephospholipid measurement, intermediate density lipoprotein measurement

LIPG ZNF335 APOH

2.50e-0399803EFO_0004639, EFO_0008595

Protein segments in the cluster

PeptideGeneStartEntry
KKKNPCNAEFQNFCI

AREG

141

P15514
KNKEKKCSYTEDAQC

APOH

301

P02749
KVQNKLDGCCYAVKR

EIF2AK4

606

Q9P2K8
NCNKCIYFEAKKKQD

BRIX1

111

Q8TDN6
YGKANDDNKIALKNC

CTNND2

621

Q9UQB3
NKLCCKSCNLYNNLT

ADAMTS2

1086

O95450
YCKKCNANASSQDAL

ADNP2

216

Q6IQ32
EASNSNKKCKRYFNE

C17orf113

11

A0A1B0GUU1
NENFKKNVLSAVCYC

QRFPR

336

Q96P65
DVYCSQCCKKINLLN

RAB11FIP4

271

Q86YS3
QKNAKYICLANKDCP

NR4A1

296

P22736
KLNLAQKCFKNCYGE

NUB1

306

Q9Y5A7
CNMKNNFICKYSDEK

LAYN

176

Q6UX15
LKCSQKCDQNKFSVK

LRP1

1231

Q07954
YCEKVKQLKLCQLSQ

ADAMTSL1

1736

Q8N6G6
NRIYDSKKCCYTCKN

MUC19

8276

Q7Z5P9
VKANCSKDDFLFNCK

DDIAS

486

Q8IXT1
NDVSDLCKLENKQYC

DDIAS

601

Q8IXT1
GNCKYKVDCACLKEN

KMT2E

451

Q8IZD2
CRKNRCNSIGYNAKK

LIPG

311

Q9Y5X9
EYANCKKSQGNVDNK

MORF4L2

161

Q15014
QQNSCYIKNKEIFCK

LHX6

106

Q9UPM6
KKKQQLSVCNKLCYA

MFSD2A

36

Q8NA29
CSQNKCNFYDNKDLE

CTSA

241

P10619
KFLQNSAKKCAQDYN

ICE2

151

Q659A1
DAAKACNLDDICKKY

GFRA1

156

P56159
KACNLNDNCKKLRSS

GFRA2

166

O00451
EQKCQLSYELNCSGK

CFAP70

551

Q5T0N1
LNFYCDSCKAKLQEQ

FRMPD3

641

Q5JV73
KQCSHQISACNKDIY

F11

101

P03951
AKNCVFLDDKKVYCQ

KMT2A

1961

Q03164
KNSCEYKLTGLQQQC

EMILIN2

341

Q9BXX0
KLYAKKECNEDCNFK

FGF7

126

P21781
AEAKLKKNRCANCFD

DCTN4

61

Q9UJW0
TKNQRDCKLTCNYGN

SCUBE3

191

Q8IX30
LQKCVFSYNSNCQEK

CYP4F22

211

Q6NT55
NFQSKANCLNTCKNK

EPPIN

116

O95925
VQKNAKYVCLANKNC

NR4A2

291

P43354
QKNAKYVCLANKNCP

NR4A3

321

Q92570
ANAYHCEKCNKKVDT

USP9X

1766

Q93008
CKQLLQDEKAKCNKY

TAX1BP1

541

Q86VP1
KQCLKDKQALQDCAS

SYNE1

2501

Q8NF91
SYDNACQIKEASCQK

TMEFF2

201

Q9UIK5
NTARKQTCLDCKKNF

RFFL

56

Q8WZ73
LIKNCDSKSQKYNCL

SHLD2

431

Q86V20
DNCYDQAKKLDSCKF

PLA2G1B

71

P04054
LKKQNGKIKYECNVC

PRDM1

566

O75626
CKKKNCTYTQVQTRS

TCEA1

266

P23193
IGNKCQRCTNSEKKY

FAM76A

81

Q8TAV0
KCLQANSYMESKCQA

CMC4

16

P56277
RDNNKCYAKIICNTK

TXNRD1

566

Q16881
KDLQARKAFNCKYCN

SNAI1

146

O95863
KIHNAKKSYQCNECE

ZIM3

271

Q96PE6
KKSYQCNECEKSFRQ

ZIM3

276

Q96PE6
DNAVYKCVKCVNKYS

ZNF341

536

Q9BYN7
LKQVKDYIKQCSKCQ

ZBTB11

106

O95625
NCTACEKAFIYKNKL

ZNF549

586

Q6P9A3
KCKECGKAFNQCSNL

ZNF724

591

A8MTY0
KCNECGKVFNQKAYL

ZNF702P

91

Q9H963
IYNKNISQKDCDCLH

TMEM9B

56

Q9NQ34
SCKSICKNYNDLQIA

TASL

116

Q9HAI6
CHCKSSQKNILYLDK

TMEM232

386

C9JQI7
NNYLTKEECLKKCAT

SPINT2

76

O43291
KKAELIKGNYKCNVC

ZNF521

921

Q96K83
YKCQICNQSFRIKKT

ZBTB41

696

Q5SVQ8
NQCVNDKNYKDALSK

SPAG1

631

Q07617
KKALQYACGNALVCD

SMC1A

606

Q14683
DLFQCSKCKKKNCTY

TCEA3

306

O75764
SKCKKKNCTYNQVQT

TCEA3

311

O75764
NKVTDNKCIACQAAK

NUP153

671

P49790
YKCKECAKAFNQSSN

ZNF43

286

P17038
NNACDNIAKISKYKR

ZNF492

511

Q9P255
KPYKCNECAKAFNQS

ZNF852

241

Q6ZMS4
EKPYKCNDCEKAFNQ

ZNF879

481

B4DU55
KNKNKQLRNYCHSCN

XKR3

431

Q5GH77
KCKECGKAYNEASNL

ZNF98

211

A6NK75
CNNACDNIAKISKYK

ZNF98

551

A6NK75
ENNTCYAKIICNKFD

TXNRD3

561

Q86VQ6
YKCEKCVRAFNQASK

ZNF117

221

Q03924
CNKIGKAFNDKANCV

ZNF510

256

Q9Y2H8
LYCKLCKRQFTSKQN

ZNF800

486

Q2TB10
DQVDKCYKCSVKQGQ

PHF8

331

Q9UPP1
CGKCRKKNCTYTQVQ

TCEA2

261

Q15560
KLYKCNDCHKVFSNA

ZNF860

396

A6NHJ4
EKPYKCNECDKAFNQ

ZNF600

271

Q6ZNG1
QCSQCSFASKNKKDL

ZNF335

1076

Q9H4Z2
KQCKCDVCGKVFNQK

ZNF468

241

Q5VIY5
YQCKECKKAFSQIAH

ZNF583

296

Q96ND8
CGKNCSDEYKKINNV

ZMYM4

711

Q5VZL5
GTNKVYFKQLCCKCQ

ZAR1L

246

A6NP61
EYKCDVCGKIFNQKQ

ZNF816

256

Q0VGE8
YCNLKDKCNKFHVCK

ZC3HAV1L

181

Q96H79